Ceccarelli et al. discovered a small-molecule inhibitor, CC0651, that selectively disrupts the activity of the human E2 enzyme, CDC34, and potently suppresses cell proliferation, leading to the accumulation of the Skp2 substrate, p27Kip1, in human cancer cell lines [116]. The gene discussed is CDKN1B; the disease is cancer.